Discover how a groundbreaking cognitive assessment tool is transforming early dementia detection with 99.9% accuracy and what this means for future treatment.

With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems long and uncertain, according to a news release.

First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec ... motivation and behavior in mice, according to new ... Dec. 17, 2024 — Engineers have modified ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

NEW YORK, Jan. 8, 2025 /PRNewswire/ -- Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, particularly in women. Levels were ...

Recent advances in molecular biology have provided unprecedented insights into the structure of amyloid fibrils associated ...

NEW YORK, Jan. 8, 2025 /PRNewswire/ -- Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer’s disease, particularly in women. Levels were ...

Posdinemab is an investigational monoclonal antibody that targets the mid-domain of Alzheimer's disease-specific ...

A new study ... the development of Alzheimer's disease in a subset of people. It is believed most humans are ... First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step ...

Building on decades of the Company's Alzheimer's research, two differentiated investigational therapies aim to slow ...